solid organ growth ep maintain neutral
invest summari maintain neutral rate pt
share revenu slightli miss factset consensu
organ growth beat estim vs ep
beat consensu penni move organ growth guidanc higher
end previou rang rais ep guidanc
continu grow revenu high end med-tech think near-term upsid
may limit think investor expect remain high given valuat
think difficult significantli beat expect given
compani top perform busi line last two quarter neurotech
instrument us knee face toughest y/i comp
 organ revenu growth slightli higher expect despit slight
revenu miss ep beat revenu miss consensu
revenu organ growth slightli higher
estim driven neurotech cc instrument cc
us knee cc benefit easi y/i comp
medic busi due product recal management said boost organ
growth bp
 mako continu deliv mako continu strong momentum
y/i instal mako robot quarter includ
us train addit surgeon total knee total
train sinc launch mako total knee quarter
ytd util rel
 manag stick oper margin improv
despit acquisit said still expect om improv
despit recent acquisit includ ktwo
acquisit said minim custom overlap ktwo
may allow expand reach minim invas
spine offer continu believ busi complementari
expect integr smoother recent spine deal
move guidanc higher expect organ top-lin growth
high end previous state rang rais
ep guidanc rais revenu
estim respect
sale estim includ contribut invuiti exclud ktwo
rais ep estim leav
estim unchang
 valuat pt base price-to-earnings multipl ep estim
disclosur section may found page
sourc compani document factset cantor fitzgerald estim
exhibit comparison cantor estim
sourc compani document factset cantor fitzgerald estim
stryker corpor million except per dilut corpor million except per share current priorcurr priorp growth growth incom excl share octob
price target base price-to-earnings multipl ep estim assum
trade premium median large-cap med-tech peer higher organ
mako total knee applic traction could stall although signific proport syk
total revenu slowdown traction temporari setback could damag investor confid
syk hip knee busi given visibl program street
hospit capit purchas cyclic syk medsurg busi sell larg piec capit
equip sale could neg affect slowdown capit spend
hospit capit spend typic depend macroeconom environ chang
regulatori requir polit pressur healthcar industri could lessen hospit
willing and/or abil invest expens capit equip
orthoped implant could come increas price pressur present syk orthoped
busi typic experi price pressur around although see anyth
specif could increas price pressur near term gener implant bundl payment
program could neg impact price time becom preval
million except per share data
sale
compani document cantor fitzgerald research
offer rang medic technolog includ orthoped medic surgic neurotechnolog spine product
compani segment includ orthopaed medsurg neurotechnolog spine corpor orthopaed segment
includ reconstruct hip knee trauma implant system relat product medsurg segment includ surgic
equip surgic navig system endoscop commun system patient handl emerg medic equip
intens care dispos product reprocess remanufactur medic devic relat product neurotechnolog
spine segment includ neurovascular product spinal implant system relat product compani product includ
implant use joint replac trauma surgeri product use rang medic specialti
